Abstract
Uridine 5′-diphospho-glucuronosyltransferases (UGTs) have been considered as a family of enzymes responsible for the glucuronidation process, a crucial phase II detoxification reaction. Among the various UGT isoforms, UGTs A10 and B7 have garnered significant attention due to their broad substrate specificity and involvement in the metabolism of numerous compounds. Recent studies have suggested that certain vitamins may exert inhibitory effects on UGT activity, thereby influencing the metabolism of drugs, environmental toxins, and endogenous substances, ultimately impacting their biological activities. In the present study, the inhibition potential of vitamins (A, B1, B2, B3, B5, B6, B7, B9, D3, E, and C) on UGT1A10 and UGT2B7 was determined using in silico and in vitro approaches. A 3-dimensional model of UGT1A10 and UGT2B7 enzymes was built using Swiss Model, ITASSER, and ROSETTA and verified using Ramachandran plot and SAVES tools. Molecular docking studies revealed that vitamins interact with UGT1A10 and UGT2B7 enzymes by binding within the active site pocket and interacting with residues. Among all vitamins, the highest binding affinity predicted by molecular docking was − 8.61 kcal/mol with vitamin B1. The in vitro studies results demonstrated the inhibition of the glucuronidation activity of UGTs by vitamins A, B1, B2, B6, B9, C, D, and E, with IC50 values of 3.28 ± 1.07 µg/mL, 24.21 ± 1.11 µg/mL, 3.69 ± 1.02 µg/mL, 23.60 ± 1.08 µg/mL, 6.77 ± 1.08 µg/mL, 83.95 ± 1.09 µg/ml, 3.27 ± 1.13 µg/mL and 3.89 ± 1.12 µg/mL, respectively. These studies provided the valuable insights into the mechanisms underlying drug-vitamins interactions and have the potential to guide personalized medicine approaches, optimizing therapeutic outcomes, and ensuring patient safety. Indeed, further research in the area of UGT (UDP-glucuronosyltransferase) inhibition by vitamins is essential to fully understand the clinical relevance and implications of these interactions. UGTs play a crucial role in the metabolism and elimination of various drugs, toxins, and endogenous compounds in the body. Therefore, any factors that can modulate UGT activity, including vitamins, can have implications for drug metabolism, drug-drug interactions, and overall health.
Similar content being viewed by others
Availability of data and material (data transparency)
These data will be made available to the reviewers and published if the paper is accepted.
Code availability (software application or custom code)
Not applicable.
References
Adiji OA, Docampo-Palacios ML, Alvarez-Hernandez A et al (2021) UGT84F9 is the major flavonoid UDP-glucuronosyltransferase in Medicago truncatula. Plant Physiol 185:1617–1637
Audet-Delage Y, Rouleau M, Villeneuve L, Guillemette C (2022) The glycosyltransferase pathway: an integrated analysis of the cell metabolome. Metabolites 12:1006
Azizi J, Ismail S, Mansor SM (2013) Mitragyna speciosa Korth leaves extracts induced the CYP450 catalyzed aminopyrine-N-demethylase (APND) and UDP-glucuronosyl transferase (UGT) activities in male Sprague-Dawley rat livers. Drug Metabol Drug Interact 28:95–105
Bailly C (2021) Atractylenolides, essential components of Atractylodes-based traditional herbal medicines: antioxidant, anti-inflammatory and anticancer properties. Eur J Pharmacol 891:173735
Bardhi K, Coates S, Watson CJ, Lazarus P (2022) Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy. Expert Rev Clin Pharmacol 15:1443–1460
Brancaccio M, Mennitti C, Cesaro A et al (2022) The biological role of vitamins in athletes’ muscle, heart and microbiota. Int J Environ Res Public Health 19:1249
Bruyère A, Declevès X, Bouzom F et al (2009) Development of an optimized procedure for the preparation of rat intestinal microsomes: comparison of hepatic and intestinal microsomal cytochrome P450 enzyme activities in two rat strains. Xenobiotica 39:22–32
Chavda VP, Patel C, Modh D et al (2022) Therapeutic approaches to amyotrophic lateral sclerosis from the lab to the clinic. Curr Drug Metab 23:200–222
Chen C, Wang C, Chen F et al (2023) Transcriptomic profiling reveals key genes of halophyte Apocyni Veneti Folium (Apocynum venetum L.) and regulatory mechanism of salt tolerance. J Plant Growth Regul 42:6565–6584
D’Andrea V, Pérez LM, Pozzi EJS (2005) Inhibition of rat liver UDP-glucuronosyltransferase by silymarin and the metabolite silibinin-glucuronide. Life Sci 77:683–692
Dadwal A, Singh V, Sharma S, Satyanarayana T (2022) Structural aspects of β-glucosidase of Myceliophthora thermophila (MtBgl3c) by homology modelling and molecular docking. J Biomol Struct Dyn 40:5211–5228
Das R, Baker D (2008) Macromolecular modeling with rosetta. Annu Rev Biochem 77:363–382
de Jesus AN, Coombes G, da Cunha KF et al (2022) In vitro metabolism of the new antifungal dapaconazole using liver microsomes. Drug Metab Pharmacokinet 47:100475
Fasco MJ, Silkworth JB, Dunbar DA, Kaminsky LS (1993) Rat small intestinal cytochromes P450 probed by warfarin metabolism. Mol Pharmacol 43:226–233
Gajula SNR, Vora SA, Dikundwar AG, Sonti R (2022) In vitro drug metabolism studies using human liver microsomes. In: Dosage forms. IntechOpen
Gregory PA, Lewinsky RH, Gardner-Stephen DA, Mackenzie PI (2004) Regulation of UDP glucuronosyltransferases in the gastrointestinal tract. Toxicol Appl Pharmacol 199:354–363
Guo D-D, Liu F, Tu Y-H et al (2016) Expression patterns of three UGT genes in different chemotype safflower lines and under MeJA stimulus revealed their potential role in flavonoid biosynthesis. PLoS One 11:e0158159
Guo F, Zhang L, Feng X, Li C (2021) Plant-derived UDP-glycosyltransferase and its molecular modification. China Biotechnol 41:78–91
Hanna M, Jaqua E, Nguyen V, Clay J (2022) Vitamins: functions and uses in medicine. Perm J 26:89–97
Hillisch A, Pineda LF, Hilgenfeld R (2004) Utility of homology models in the drug discovery process. Drug Discov Today 9:659–669
Ikushiro S, Emi Y, Iyanagi T (1995) Identification and analysis of drug-responsive expression of UDP-glucuronosyltransferase family 1 (UGT1) isozyme in rat hepatic microsomes using anti-peptide antibodies. Arch Biochem Biophys 324:267–272
Jade D, Gupta S, Mohan S et al (2023) Homology modelling and molecular simulation approach to prediction of B-cell and T-cell epitopes in an OMP25 peptide vaccine against Brucella abortus. Mol Simul 49:441–452
Jiang Z, Gao H, Liu R et al (2022) Key glycosyltransferase genes of Panax notoginseng: identification and engineering yeast construction of rare ginsenosides. ACS Synth Biol 11:2394–2404
Kaminsky LS, Fasco MJ (1992) Small intestinal cytochromes P450. Crit Rev Toxicol 21:407–422
Kumar RR, Singh L, Thakur A et al (2022) Role of vitamins in neurodegenerative diseases: a review. CNS Neurol Disord Drug Targets Former Curr Drug Targets CNS Neurol Disord 21:766–773
Li J, Qu G, Shang N et al (2021) Near-perfect control of the regioselective glucosylation enabled by rational design of glycosyltransferases. Green Synth Catal 2:45–53
Li X, Wang C, Chen J et al (2022a) Potential interactions among myricetin and dietary flavonols through the inhibition of human UDP-glucuronosyltransferase in vitro. Toxicol Lett 358:40–47
Li J, Mu S, Yang J et al (2022b) Glycosyltransferase engineering and multi-glycosylation routes development facilitating synthesis of high-intensity sweetener mogrosides. Iscience 25:105222
Liu X, Cao Y-F, Dong P-P et al (2017) The inhibition of UDP-glucuronosyltransferases (UGTs) by vitamin A. Xenobiotica 47:376–381
Lohning AE, Levonis SM, Williams-Noonan B, Schweiker SS (2017) A practical guide to molecular docking and homology modelling for medicinal chemists. Curr Top Med Chem 17:2023–2040
Luquita MG, Pozzi EJS, Catania VA, Mottino AD (1994) Analysis of p-nitrophenol glucuronidation in hepatic microsomes from lactating rats. Biochem Pharmacol 47:1179–1185
Nomura Y, Seki H, Suzuki T et al (2019) Functional specialization of UDP-glycosyltransferase 73P12 in licorice to produce a sweet triterpenoid saponin, glycyrrhizin. Plant J 99:1127–1143
Oda S, Fukami T, Yokoi T, Nakajima M (2015) A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development. Drug Metab Pharmacokinet 30:30–51
Oeren M, Walton PJ, Suri J et al (2022) Predicting regioselectivity of AO, CYP, FMO, and UGT metabolism using quantum mechanical simulations and machine learning. J Med Chem 65:14066–14081
Pande S, Patel C, Sarkar D, Acharya S (2021) Lactobacillus rhamnosus UBLR-58 and diclofenac potentiate the anti-Alzheimer activity of curcumin in mice. Curr Enzyme Inhib 17:49–56
Patel C, Pande S, Acharya S (2020) Potentiation of anti-Alzheimer activity of curcumin by probiotic Lactobacillus rhamnosus UBLR-58 against scopolamine-induced memory impairment in mice. Naunyn Schmiedebergs Arch Pharmacol 393:1955–1962
Patel C, Pande S, Sagathia V et al (2023a) Nanocarriers for the delivery of neuroprotective agents in the treatment of ocular neurodegenerative diseases. Pharmaceutics 15:837
Patel CA, Pande S, Shukla P et al (2023b) Antimalarial drug resistance: trends, mechanisms, and strategies to combat antimalarial resistance. In: Shegokar R, Pathak Y (eds) Malarial drug delivery systems: advances in treatment of infectious diseases. Springer, Cham, pp 43–69
Picard N, Ratanasavanh D, Prémaud A et al (2005) Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism. Drug Metab Dispos 33:139–146
Pisoschi AM, Pop A, Iordache F et al (2022) Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy. Eur J Med Chem 232:114175
Pitman MR, Menz RI (2006) Methods for protein homology modelling. In: Arora KD, Berka RM, Singh GB (ed) Applied mycology and biotechnology. Elsevier, pp 37–59
Pop TL, Sîrbe C, Benţa G et al (2022) The role of vitamin D and vitamin D binding protein in chronic liver diseases. Int J Mol Sci 23:10705
Qi D, Li H, Liang C et al (2023) Herb-drug interaction of Xingnaojing injection and Edaravone via pharmacokinetics, mixed inhibition of UGTs, and molecular docking. Phytomedicine 112:154696
Sabale VB, Ingale AG (2016) Homology modelling and docking studies of 3-oxoacyl synthase II protein of Neisseria meningitidis. Int J Sci Eng Res 7:1564–1572
Samanta P, Doerksen RJ (2023) Identifying FmlH lectin-binding small molecules for the prevention of Escherichia coli-induced urinary tract infections using hybrid fragment-based design and molecular docking. Comput Biol Med 163:107072
Santos PM, Sá-Correia I (2007) Characterization of the unique organization and co-regulation of a gene cluster required for phenol and benzene catabolism in Pseudomonas sp. M1. J Biotechnol 131:371–378
Shahzan MS, Girija AS, Priyadharsini JV (2019) A computational study targeting the mutated L321F of ERG11 gene in C. albicans, associated with fluconazole resistance with bioactive compounds from Acacia nilotica. J Mycol Médicale 29:303–309
Shan L, Shi X, Hu T et al (2022) In vitro differences in toddalolactone metabolism in various species and its effect on cytochrome P450 expression. Pharm Biol 60:1591–1605
Sharma R, Rawat V, Suresh C (2014a) Genome-wide identification and tissue-specific expression analysis of UDP-glycosyltransferases genes confirm their abundance in Cicer arietinum (Chickpea) genome. PLoS One 9:e109715
Sharma R, Panigrahi P, Suresh C (2014b) In-Silico analysis of binding site features and substrate selectivity in plant flavonoid-3-O glycosyltransferases (F3GT) through molecular modeling, docking and dynamics simulation studies. PLoS One 9:e92636
Sill JM, Fear EC (2005) Tissue sensing adaptive radar for breast cancer detection—experimental investigation of simple tumor models. IEEE Trans Microw Theory Tech 53:3312–3319
Soars MG, Petullo DM, Eckstein JA et al (2004) An assessment of UDP-glucuronosyltransferase induction using primary human hepatocytes. Drug Metab Dispos 32:140–148
Tripathi SP, Prajapati R, Verma N, Sangamwar AT (2016) Predicting substrate selectivity between UGT1A9 and UGT1A10 using molecular modelling and molecular dynamics approach. Mol Simul 42:270–288
Weiser MM (1973) Intestinal epithelial cell surface membrane glycoprotein synthesis. I. An indicator of cellular differentiation. J Biol Chem 248:2536–2541
Wells PG, Mackenzie PI, Chowdhury JR et al (2004) Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 32:281–290
Xu P, Wang L, Liu X et al (2023) Vitamin C promoted refractory organic contaminant elimination in the zero-valent iron/peracetic acid system: efficiency, mechanism and effects of various parameters. Chemosphere 326:138481
Zhai X-F, Yi Y, Yu R et al (2022) Rational design of a highly selective UGT1A1 probe and its application in drug discovery. Sens Actuators B Chem 364:131826
Zhang QY, Wikoff J, Dunbar D, Kaminsky L (1996) Characterization of rat small intestinal cytochrome P450 composition and inducibility. Drug Metab Dispos Biol Fate Chem 24:322–328
Zhang D, Chando TJ, Everett DW et al (2005) In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation. Drug Metab Dispos 33:1729–1739
Zhang L, Zhang Y, Zhao P, Huang S-M (2009) Predicting drug–drug interactions: an FDA perspective. AAPS J 11:300–306
Zhou J, Tracy TS, Remmel RP (2010) Bilirubin glucuronidation revisited: proper assay conditions to estimate enzyme kinetics with recombinant UGT1A1. Drug Metab Dispos 38:1907–1911
Zoghlami M, Oueslati M, Basharat Z et al (2023) Inhibitor assessment against the LpxC enzyme of antibiotic-resistant Acinetobacter baumannii using virtual screening, dynamics simulation, and in vitro assays. Mol Inform 42:2200061
Zulkiffli MH, Salleh NM, Mahmud R, Ismail S (2019) Inhibitory effects of Ficus deltoidea extracts on UDP-glucuronosyltransferase and glutathione S-transferase drug-metabolizing enzymes. Pharmacogn Res 11:210–218
Funding
The authors did not receive support from any organization for the submitted work.
Author information
Authors and Affiliations
Contributions
The authors declare that all data were generated in-house and that no paper mill was used.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare that are relevant to the content of this article.
Ethics approval
IAEC approval granted to conduct research study (LMCP/IAEC/2200/25E).
Consent to participate
Not applicable.
Consent for publication
Authors give consent for information to be published in the Journal of Computer-Aided Molecular Design.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pande, S., Patel, C.A., Dhameliya, T.M. et al. Inhibition of Uridine 5′-diphospho-glucuronosyltransferases A10 and B7 by vitamins: insights from in silico and in vitro studies. In Silico Pharmacol. 12, 8 (2024). https://doi.org/10.1007/s40203-023-00182-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40203-023-00182-0